Regulation of Cell Growth and Transformation by the Epidermal Growth Factor Receptor

  • Joseph Schlessinger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 234)


Epidermal growth factor (EGF) is a small peptide growth factor which mediates its response by a membrane glcoprotein denoted as the EGF-receptor,(reviewed in 1–2). Following the purification of the EGF-receptor,3 and its partial sequencing,4 the complete primary structure of the EGF-receptor was deduced from nucleotide sequence of cDNA clones.5 The mature receptor is composed of 1,186 amino acid residues that are preceded at the NH2-terminal end by a signal peptide of 24 hydrophobic amino acids. The signal peptide is cleaved after insertion of the nascent receptor into the membrane of the endoplasmic reticulum. Cotranslationally, the receptor is glycosylated and transported through the Golgi apparatus to the plasma membrane. The mature receptor is composed of three major structural elements. An extracellular EGF-binding domain composed of 621 amino acid residues, anchored to the plasma membrane by a single transmembrane region of 23 hydrophobic amino acids. The transmembrane region is followed by a sequence of mostly basic residues; a feature common to many membrane proteins.


Epidermal Growth Factor Receptor Epidermal Growth Factor Chinese Hamster Ovary Cell Wild Type Receptor Mature Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G. Carpenter and S. Cohen, Epidermal growth factor, Annu. Rev. Biochem. 48: 193–216 (1979).CrossRefGoogle Scholar
  2. 2.
    J. Schlessinger, A.B. Schreiber, A. Levi, I. Lax, T. Libermann and Y. Yarden, Regulation of cell proliferation by epidermal growth factor, CRC Crit. Rev. Biochem. 14: 93–111, (1983).CrossRefGoogle Scholar
  3. 3.
    Y. Yarden, I. Harari and J. Schlessinger, Purification of an active EGF-receptor kinase with monoclonal anti-receptor antibodies, J. Biol. Chem. 260. 315–319 (1985).PubMedGoogle Scholar
  4. 4.
    J. Downward, Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger and M.D. Waterfield, Close'similarity of epidermal growth factor receptor and V-erb-B oncogene protein sequences, Nature (Loud.) 307: 521–527 (1984).CrossRefGoogle Scholar
  5. 5.
    A. Ullrich, L. Coussens, J.S. Hayflick, T.J. Dull, A. Gray, A.W. Tam, J. Lee, Y. Yarden, T.A. Libermann, J. Schlessinger, J. Downward, E.L.V. Mayes, N. Whittle, M.D. Waterfield and P.H. Seeburg, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A-431 epidermoid carcinoma cells, Nature (Lond.) 309: 418–425 (1984).CrossRefGoogle Scholar
  6. 6.
    T. Hunter and J.A. Cooper, Protein-tyrosine kinases, Annu. Rev. Biochem. 54: 897–930 (1985).CrossRefGoogle Scholar
  7. 7.
    P.J. Betrics and G.N. Gill, Self-phosphorylation enhances the protein-kinase activity of the epidermal growth factor receptor, J. Biol. Chem. 260: 14642–14647 (1985).Google Scholar
  8. 8.
    Y. Ebina, L. Ellis, K. Jarnagin, M. Edery, L. Graf, E. Clausner, J.-H. Ou, F. Masiarz, X.W. Kan, I.D. Goldfine, R.A. Roth and N.J. Rutter, The human insulin receptor cDNA: the structural basis for hormone activated transmembrane signalling, Cell 40: 747–758.Google Scholar
  9. 9.
    R. Ullrich, J.R. Bell, E.Y. Chen, R. Herrera, L.M. Petruzzelli, T.J. Dull, A. Gray, L. Coussens, X.-C. Liao, M. Tsubokawa, A. Mason, P.H. Seeburg, C. Grunfeld, D.M. Rosenfeld and J. Ramachandran, Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes, Nature (Lond.) 313: 756–761 (1985).CrossRefGoogle Scholar
  10. 10.
    E. Livneh, L. Glaser, D. Segal, J. Schlessinger and B.Z. Shilo, The drosphila EGF-receptor gene homolog conservation of both hormone binding and kinase domains, Cell 40: 599–607 (1985).PubMedCrossRefGoogle Scholar
  11. 11.
    T. Yamamoto, T. Nishida, M. Miyajima, S. Kawai, T. Ooi and K. Toyoshima, The erb-B gene of avian erythroblastosis virus is a member of the src gene family, Cell 35: 71–78 (1983b).PubMedCrossRefGoogle Scholar
  12. 12.
    R. Kris, I. Lax, M. Gullick, M. Waterfield, A. Ullrich, M. Fridkin and J. Schlessinger, Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF-receptor and V-erb-B proteins, Cell 40: 619–625 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    I. Lax, R. Kris, I. Sasson, A. Ullrich, M.J. Hayman, H. Beug and J. Schlessinger, Activation of C-erb-B in avian leukosis virus-induced erythroblastosis leads to the expression of a truncated EGF-receptor kinase, EMBO J. (Eur. Mol. Biol. Organ.) 4: 3179–3182 (1985).Google Scholar
  14. 14.
    T.W. Nilsen, P.A. Maroney, R.G. Goodwin, F.M. Rottman, L.B. Crittenden, M.A. Raines and H.-J. Kung, C-erb-B activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF-receptor, Cell 41: 719–726 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    G.J. Todaro, C. Fryling and J.E. DeLarco, Transforming growth factors produced by certain human tumor cells: polypeptides that interact with human EGF-receptors, Proc. Natl. Acad. Sci USA 77: 5258–5262 (1980).PubMedCrossRefGoogle Scholar
  16. 16.
    T.A. Libermann, H.R. Nussbaum, N. Razon, R. Kris, i. Lax, M. Soreq, N. Whittle, M.D. Waterfield, A. Ullrich and J. Schlessinger, Amplification, enhanced expression and possible rearrangement of the EGF-receptor gene in primary human brain tumors of glial origin, Nature (Lond.) 313: 144–147 (1985).CrossRefGoogle Scholar
  17. 17.
    A.C. King, and P. Cuatrecasas, Resolution of high and low affinity epidermal growth factor receptors: inhibition of high affinity component by low temperature, cycloheximide and phorbol esters, J. Biol. Chem. 257: 3053–3060 (1982).PubMedGoogle Scholar
  18. 18.
    K.D. Brown, P. Dicker and E. Rozengurt, Inhibition of epidermal growth factor binding to surface receptors by tumor promoters, Biochem. Biophys. Res. Commun. 86: 1037–1043 (1979).CrossRefGoogle Scholar
  19. 19.
    M. Shoyab, J.E. DeLarco and G.J. Todaro, Biologically active phorbol esters specifically alter affinity of epidermal growth factor receptors, Nature (Lond.) 279: 387–391 (1979).CrossRefGoogle Scholar
  20. 20.
    C. Cochet, G.N. Gill, J. Meisenheider, J.A. Cooper and T. hunter, C-kinase phosphorylates the epidermal growth factor-receptor and reduces its epidermal growth factor stimulated tyrosine protein kinase activity, J. Biol. Chem. 259: 2553–2558 (1984).PubMedGoogle Scholar
  21. 21.
    S. Iwashita and C.F. Fox, Epidermal growth factor and potent tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctively different manner in human epidermal carcinoma A-431 cells, J. Biol. Chem. 259: 2559–2567 (1984).PubMedGoogle Scholar
  22. 22.
    T. Hunter, N. Ling and N.A. Cooper, Protein Kinase-C phosphorylation of the EGF-receptor at a threonine residue close to the cytoplasmic face of the plasma membrane, Nature (Lond.) 314: 480–483 (1984).CrossRefGoogle Scholar
  23. 23.
    R.J. Davis and M.P. Czech, Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654, Proc. Natl. Acad. Sci. USA 82: 1974–1978 (1985).PubMedCrossRefGoogle Scholar
  24. 24.
    Y. Yarden and J. Schlessinger, Self-phosphorylation of EGF-receptor:evidence for a model of intermolecular allosteric activation, Biochemistry 26: 1434–1442 (1987).PubMedCrossRefGoogle Scholar
  25. 25.
    Y. Yarden and J. Schlessinger, EGF induces rapid, reversible aggregation of the purified EGF-receptor, Biochemistry 26: 1443–1451 (1987).PubMedCrossRefGoogle Scholar
  26. 26.
    M.S. Brown, R.G.W. Anderson and J.R. Goldstein, Recycling receptors: the round trip itinerary of migrant membrane proteins, Cell 32: 663–667 (1983).PubMedCrossRefGoogle Scholar
  27. 27.
    M.A. Lehrman, J.L. Goldstein, M.S. Brown, D.W. Russ-ell and W.J. Schneider, Internalizes-tion defective LDL-receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain, Cell 41: 735–743 (1985).PubMedCrossRefGoogle Scholar
  28. 28.
    M.A. Lehrman, W.J. Schneider, T.C. Sudhof, M.S. Brown, J.L. Goldstein and D.W. Russell, Mutation in LDL-receptor: Alu-Alu-recombination deletes exons encoding transmembrane and cytoplasmic domains, Science (Wash. DC) 227: 140–146 (1985).CrossRefGoogle Scholar
  29. 29.
    E. Livneh, M. Benveniste, R. Prywes, S. Felder, Z. Kam and J. Schlessinger, Large deletions in the cytoplasmic kinase domain of epidermal growth factor receptor do not affect its lateral mobility, J. Cell Biol. 103: 327–331 (1986).PubMedCrossRefGoogle Scholar
  30. 30.
    E. Livneh, R. Prywes, O. Kashles, N. Reiss, I. Sasson, y. Mory, A. Ullrich and J. Schlessinger, Reconstitution of human EGF-receptors and its deletion mutants in cultured hamster cells, J. Biol. Chem. 261: 12490–12497 (1986).Google Scholar
  31. 31.
    R. Prywes, E. Livneh, A. Ullrich and J. Schlessinger, Mutations in the cytoplasmic domain of EGF-receptors affect EGF-binding and receptor internalization, EMBO J. (Eur. Mol. Biol. Organ.) 5: 2179–2190 (1986).Google Scholar
  32. 32.
    C.-R. Lin, S.-W. Chen, C.S. Lazar, D.C. Carpenter, G.N. Gill, R.N. Evans and M.G. Rosenfeld, Protein kinase-C phosphorylation at Thr654 of the unoccupied EGF-receptor and EGF binding regulate functional receptor loss by independent mechanisms, Cell 44: 839–848 (1986).PubMedCrossRefGoogle Scholar
  33. 33.
    E. Livneh, T.J. Dull, R. Prywess, A. Ullrich and J. Schlessinger, Release of phorbol ester-induced mitogenic block by mutation at Thr654 of EGF-receptor, J. Biol. Chem., submitted.Google Scholar
  34. 34.
    P. Dicker and E. Rozengurt, Stimulation of DNA synthesis by tumor promoters and pure mitogenic factors, Nature (Lond.) 279: 723–726 (1978).CrossRefGoogle Scholar
  35. 35.
    J.F. Lechner and M.E. Kaighn, EGF-growth promoting activity is neutralized by phorbol esters, Cell Biol. Int. Rep. 4: 23–28 (1980).Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Joseph Schlessinger
    • 1
    • 2
  1. 1.Rorer Biotechnology, Inc.RockvilleUSA
  2. 2.Department of Chemical ImmunologyThe Weizmann Institute of ScienceRehovotIsrael

Personalised recommendations